Australian biotechs fight over Progen
This article was originally published in Scrip
Executive Summary
The Melbourne biotech firm Cytopia is challenging a merger between the Australian biotechs Progen Pharmaceuticals and Avexa, saying it can offer a better deal to Progen shareholders.